![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
,2
* Arkansas Children's Nutrition Center, Little Rock, AR 722 02; Departments of Physiology/Biophysics, ** Pharmaceutical Sciences, and Pharmacology/Toxicology, University of Arkansas for Medical Sciences, Little Rock, AR 72202; Comparative Medicine Clinical Research Center, Wake Forest University School of Medicine, Winston-Salem, NC 27157; and Yerkes National Primate Center and Emory University, Atlanta, GA
2 To whom correspondence should be addressed. E-mail: badgerthomasm{at}uams.edu.
Various physiologic effects of soy food consumption have been attributed to the estrogenic actions of isoflavones. The order of estrogen receptor binding potency of soy-derived isoflavone aglycones is equol > genistein > daidzein, and their conjugates are less potent. Because the metabolic profile may be an important determinant of bioactivity after soy intake, we studied the serum and urine isoflavone concentrations in 3 animal models and compared them with isoflavone profiles in women. Female Sprague-Dawley rats, Hampshire/Duroc Cross pigs, cynomolgus monkeys, and women were fed diets containing soy protein isolate. Isoflavones and their metabolites were measured by LC-MS or electrochemical detection. Equol represented 
77 and 52% (molar ratio) of summed serum isoflavones (isoflavones plus metabolites) in rats and cynomolgus monkeys, respectively. Equol was undetectable in pig serum and human plasma, but daidzein and genistein contributed >88% of summed circulating isoflavones. Monkey and rat urine contained high levels of aglycones (>85% and >32%, respectively), whereas pigs and women excreted isoflavone mainly in the form of glucuronides (>80%), with <10% as aglycones. Isoflavones in human plasma were predominantly glucuronides (75%) with 24% as sulfates and <1% as aglycones; in monkey serum, however, 64% of isoflavones were sulfates, 30% glucuronides, and 6% aglycones. Equol was also a major serum metabolite of 6-mo-old rhesus monkeys (80% of summed isoflavones). Thus, there were significant interspecies differences in isoflavone metabolism, and the overall metabolic profile of pigs was closer to that of women than that of rats or monkeys.
KEY WORDS: • isoflavone • daidzein • genistein • equol • interspecies difference
This article has been cited by other articles:
|
|
 |
|
  K. D. Setchell, X. Zhao, P. Jha, J. E Heubi, and N. M Brown The pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers Am. J. Clinical Nutrition, October 1, 2009; 90(4): 1029 - 1037. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-R. Chen, O. P. Lazarenko, M. L. Blackburn, J. V. Badeaux, T. M. Badger, and M. J. J. Ronis Infant Formula Promotes Bone Growth in Neonatal Piglets by Enhancing Osteoblastogenesis through Bone Morphogenic Protein Signaling J. Nutr., October 1, 2009; 139(10): 1839 - 1847. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Ronis, Y. Chen, J. Badeaux, and T. M. Badger Dietary Soy Protein Isolate Attenuates Metabolic Syndrome in Rats via Effects on PPAR, LXR, and SREBP Signaling J. Nutr., August 1, 2009; 139(8): 1431 - 1438. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Singhal, K. Shankar, T. M Badger, and M. J Ronis Hepatic gene expression following consumption of soy protein isolate in female Sprague-Dawley rats differs from that produced by 17{beta}-estradiol treatment J. Endocrinol., July 1, 2009; 202(1): 141 - 152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M Badger, J. M Gilchrist, R T. Pivik, A. Andres, K. Shankar, J.-R. Chen, and M. J Ronis The health implications of soy infant formula Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1668S - 1672S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-R. Chen, R. Singhal, O. P. Lazarenko, X. Liu, W. R. Hogue, T. M. Badger, and M. J. J. Ronis Short Term Effects on Bone Quality Associated with Consumption of Soy Protein Isolate and Other Dietary Protein Sources in Rapidly Growing Female Rats Experimental Biology and Medicine, November 1, 2008; 233(11): 1348 - 1358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Orgaard and L. Jensen The Effects of Soy Isoflavones on Obesity Experimental Biology and Medicine, September 1, 2008; 233(9): 1066 - 1080. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bieger, R. Cermak, R. Blank, V. C. J. de Boer, P. C. H. Hollman, J. Kamphues, and S. Wolffram Tissue Distribution of Quercetin in Pigs after Long-Term Dietary Supplementation J. Nutr., August 1, 2008; 138(8): 1417 - 1420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nagarajan, R. L. Burris, B. W. Stewart, J. E. Wilkerson, and T. M. Badger Dietary Soy Protein Isolate Ameliorates Atherosclerotic Lesions in Apolipoprotein E-Deficient Mice Potentially by Inhibiting Monocyte Chemoattractant Protein-1 Expression J. Nutr., February 1, 2008; 138(2): 332 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Noriega-Lopez, A. R. Tovar, M. Gonzalez-Granillo, R. Hernandez-Pando, B. Escalante, P. Santillan-Doherty, and N. Torres Pancreatic Insulin Secretion in Rats Fed a Soy Protein High Fat Diet Depends on the Interaction between the Amino Acid Pattern and Isoflavones J. Biol. Chem., July 13, 2007; 282(28): 20657 - 20666. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Wood, T. C. Register, and J.M. Cline Soy isoflavonoid effects on endogenous estrogen metabolism in postmenopausal female monkeys Carcinogenesis, April 1, 2007; 28(4): 801 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Messina, W. McCaskill-Stevens, and J. W. Lampe Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings. J Natl Cancer Inst, September 20, 2006; 98(18): 1275 - 1284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nagarajan, B. W. Stewart, and T. M. Badger Soy Isoflavones Attenuate Human Monocyte Adhesion to Endothelial Cell-Specific CD54 by Inhibiting Monocyte CD11a J. Nutr., September 1, 2006; 136(9): 2384 - 2390. [Abstract] [Full Text] [PDF]
|
|
